This might have been caused by an upregulation of 5-LOX in critical COVID-19, but not in severe patients, as previously suggested by other authors who observed an increase in 5-LOX-derived mediators in the sera of ICU COVID-19 patients at day 4 post-admission [55]. This evidence concerns the gene ALOX5 and COVID-19.